Inhibrx Biosciences, Inc.
INBX나스닥Biological Products, (No Diagnostic Substances)US미국
30일 공시 수
1건
최근 2026.10.14
90일 내부자 순매수
+84억 9,569만원
순매수
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 15건
- US미국임원·주요주주 소유중요도 높음2026.10.144 · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4 · 2026.10.14
- US미국주요사항·수시공시중요도 낮음2026.09.298-K · Current report (Items 7.01, 9.01)
Inhibrx Biosciences, Inc.INBX
8-K · 2026.09.29 06:03 KST
- US미국임원·주요주주 소유중요도 높음2026.09.284 · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4 · 2026.09.28
- US미국임원·주요주주 소유중요도 보통2026.09.234 · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4 · 2026.09.23
- US미국임원·주요주주 소유중요도 낮음2026.09.18정정4/A · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4/A · 2026.09.18
- US미국임원·주요주주 소유중요도 낮음2026.09.18정정4/A · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4/A · 2026.09.18
- US미국임원·주요주주 소유중요도 낮음2026.09.18정정4/A · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4/A · 2026.09.18
- US미국임원·주요주주 소유중요도 낮음2026.09.18정정4/A · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4/A · 2026.09.18
- US미국임원·주요주주 소유중요도 보통2026.09.174 · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4 · 2026.09.17
- US미국임원·주요주주 소유중요도 보통2026.09.154 · Statement of changes in beneficial ownership
Inhibrx Biosciences, Inc.INBX
Form 4 · 2026.09.15